Contents

Current Radiopharmaceuticals, Volume 9 - Number 1

Meet Our Editorial Board Member

, 9(1): 1

Ambikalmajan M.R. Pillai


DOI: 10.2174/187447100901151123124103




Editorial

Editorial Review 2015

, 9(1): 2 - 5

Sean L. Kitson and Luigi Mansi


DOI: 10.2174/187447100901151123124434




Editorial

Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)

, 9(1): 6 - 7

Ambikalmajan M.R. Pillai and Furn F. (Russ) Knapp


DOI: 10.2174/187447100901151123124826




Overview of Development and Formulation of 177Lu-DOTA-TATE for PRRT

, 9(1): 8 - 18

Wouter A.P. Breeman, Ho Sze Chan, Rory M.S. de Zanger, Mark K. Konijnenberg and Erik de Blois


DOI: 10.2174/1874471008666150313111131




Lutetium-177 Labeled Peptides: The European Institute of Oncology Experience

, 9(1): 19 - 32

Angela Carollo, Stefano Papi and Marco Chinol


DOI: 10.2174/1874471008666150313111633




Lutetium-177 Labeled Bombesin Peptides for Radionuclide Therapy

, 9(1): 33 - 43

Tamila Stott Reynolds, Rajendra P. Bandari, Zongrun Jiang and Charles J. Smith


DOI: 10.2174/1874471008666150313112922




Radioimmunotherapy of Metastatic Prostate Cancer with 177Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody

, 9(1): 44 - 53

Shankar Vallabhajosula, Anastasia Nikolopoulou, Yuliya S. Jhanwar, Gurveen Kaur, Scott T. Tagawa, David M. Nanus, Neil H. Bander and Stanley J. Goldsmith


DOI: 10.2174/1874471008666150313114005




Development and biological studies of 177Lu-DOTA-rituximab for the treatment of Non-Hodgkin’s lymphoma

, 9(1): 54 - 63

Adriana V.F. Massicano, Priscilla B. Pujatti, Lais F. Alcarde, Miriam F. Suzuki, Patrick J. Spencer and Elaine B. Araújo


DOI: 10.2174/1874471008666150313103849




Evaluation of 177Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy

, 9(1): 64 - 70

Sudipta Chakraborty, Lajos Balogh, Tapas Das, András Polyák, Gábor Andócs, Domokos Máthé, Réka Király, Julianna Thuróczy, Pradip R. Chaudhari, Gyozo A. Jánoki, Gergely Jánoki, Sharmila Banerjee and M. R.A. Pillai


DOI: 10.2174/1874471008666150312164255




Pharmacokinetic, Dosimetry and Toxicity Study of 177Lu-EDTMP in Patients: Phase 0/I study

, 9(1): 71 - 84

Chandrasekhar Bal, Geetanjali Arora, Praveen Kumar, Nishikant Damle, Tapas Das, Sudipta Chakraborty, Sharmila Banerjee, Meera Venkatesh, John J. Zaknun and M. R.A. Pillai


DOI: 10.2174/1874471008666150313105000




177Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay

, 9(1): 85 - 93

Henia Balter, Trindade Victoria, Terán Mariella, Gaudiano Javier, Ferrando Rodolfo, Paolino Andrea, Rodriguez Graciela, Hermida Juan, De Marco Eugenia and Oliver Patricia


DOI: 10.2174/1874471008666150313112620




Theranostic Applications of Lutetium-177 in Radionuclide Therapy

, 9(1): 94 - 101

Tapas Das and Sharmila Banerjee


DOI: 10.2174/1874471008666150313114644




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science